SBC Medical Group (NASDAQ:SBC) Rating Increased to Buy at Wall Street Zen

by · The Cerbat Gem

Wall Street Zen upgraded shares of SBC Medical Group (NASDAQ:SBC – Free Report) from a hold rating to a buy rating in a report issued on Saturday morning.

A number of other research analysts have also recently commented on SBC. Weiss Ratings cut shares of SBC Medical Group from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 22nd. BTIG Research restated a “buy” rating and issued a $8.00 price objective on shares of SBC Medical Group in a report on Thursday. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $8.50.

Check Out Our Latest Report on SBC Medical Group

SBC Medical Group Price Performance

SBC opened at $3.66 on Friday. The company has a current ratio of 3.82, a quick ratio of 3.78 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $375.44 million, a P/E ratio of 7.79 and a beta of 0.59. The stock has a 50-day moving average price of $3.08 and a 200-day moving average price of $3.56. SBC Medical Group has a 12-month low of $2.78 and a 12-month high of $5.07.

SBC Medical Group (NASDAQ:SBC – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.10 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.02). The firm had revenue of $49.19 million for the quarter, compared to analysts’ expectations of $45.37 million. SBC Medical Group had a net margin of 27.99% and a return on equity of 18.81%. Equities analysts predict that SBC Medical Group will post 0.47 earnings per share for the current fiscal year.

Institutional Trading of SBC Medical Group

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. BlackRock Inc. purchased a new position in shares of SBC Medical Group in the second quarter worth $2,846,000. Geode Capital Management LLC purchased a new stake in SBC Medical Group during the 2nd quarter valued at $455,000. Segall Bryant & Hamill LLC purchased a new stake in SBC Medical Group during the 1st quarter valued at $340,000. Millennium Management LLC bought a new stake in SBC Medical Group in the 3rd quarter worth $219,000. Finally, Bank of New York Mellon Corp bought a new stake in SBC Medical Group in the 2nd quarter worth $83,000. Institutional investors own 60.82% of the company’s stock.

Key Headlines Impacting SBC Medical Group

Here are the key news stories impacting SBC Medical Group this week:

  • Positive Sentiment: Strong second-quarter growth: SBC reported revenue of $49.19 million, up 13% year over year and ahead of the $45.37 million analyst estimate. Net income jumped 335%, while adjusted EBITDA increased 32%, indicating improved profitability following the company’s restructuring. SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results
  • Positive Sentiment: Ambitious clinic expansion: Management outlined a goal of reaching 1,000 clinics by 2035 and identified as much as $15 million in potential annual fee revenue. The targets support the company’s long-term growth narrative and could improve recurring revenue if executed successfully. SBC targets 1,000 clinics by 2035 while outlining $15M annual fee upside
  • Positive Sentiment: Analyst confidence: BTIG Research reaffirmed its “buy” rating and set an $8.00 price target, implying substantial upside from the recent trading level. BTIG Research rating information
  • Neutral Sentiment: Key earnings caveat: Quarterly EPS was $0.10, below the $0.12 consensus estimate. However, the revenue beat and sharp increases in net income and EBITDA may be receiving greater attention from investors.
  • Negative Sentiment: Execution risk remains: The 1,000-clinic objective extends through 2035, so achieving the projected fee opportunity will depend on sustained expansion, successful integration and continued profitability improvements. SBC Q2 2026 earnings call transcript

About SBC Medical Group

(Get Free Report)

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.

Featured Stories